Empros Pharma (Sweden)
In 2020 the Board of Directors was strengthened by new members. Empros Pharma is an agile and focused company where all investments go directly into the progress of the weight management drug project.
Basic Information
- Category: business
- Founded: 2013
- Website: http://emprospharma.com/
Documented Facts
- Phone: 687-102.0273 (No linked source recorded for this statement.)
- Email: group-233@2x-300x50-1.png (No linked source recorded for this statement.)
Evidence and Sources
- Empros Pharma (Sweden) — Official Site (official)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Empros Pharma (Sweden).
- Canonical profile: https://brandsource.ai/brands/empros-pharma-sweden
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/empros-pharma-sweden/json-ld
- Citation profile API: https://brandsource.ai/api/brands/empros-pharma-sweden/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (80/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
In 2020 the Board of Directors was strengthened by new members. Empros Pharma is an agile and focused company where all investments go directly into the progress of the weight management drug project.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.